acetylcysteine injection, solution
stelis biopharma limited - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine injection is indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion (rsi). acetylcysteine injection is contraindicated in patients with a previous hypersensitivity reaction to acetylcysteine [see warnings and precautions ( 5.1 )] . risk summary limited published case reports and case series of pregnant women exposed to acetylcysteine during various trimesters are not sufficient to inform any drug associated risk. delaying treatment of acetaminophen overdose may increase the risk of maternal or fetal morbidity and mortality [see clinical considerations]. reproduction studies in rats and rabbits following oral administration of acetylcysteine during the period of organogenesis at doses similar to the total intravenous dose (based on the body surface area) did not cause any adverse effects to the fetus. the estimated background r
acetylcysteine injection, solution
xellia pharmaceuticals usa llc - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine injection is indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion (rsi). acetylcysteine injection is contraindicated in patients with a previous hypersensitivity reaction to acetylcysteine [see warnings and precautions (5.1)]. risk summary limited published case reports and case series of pregnant women exposed to acetylcysteine during various trimesters are not sufficient to inform any drug associated risk. delaying treatment of acetaminophen overdose may increase the risk of maternal or fetal morbidity and mortality [see clinical considerations]. reproduction studies in rats and rabbits following oral administration of acetylcysteine during the period of organogenesis at doses similar to the total intravenous dose (based on the body surface area) did not cause any adverse effects to the fetus. the estimated background risk of major birth defects and misc
acetylcysteine 600mg tablets
ennogen healthcare ltd - acetylcysteine - oral tablet - 600mg
acetylcysteine sandoz effervescent tablet 600mg
sandoz products malaysia sdn. bhd. - acetylcysteine -
acetylcysteine sandoz effervescent tablet 200mg
sandoz products malaysia sdn. bhd. - acetylcysteine -
acetylcysteine stirling anglian 600 mg effervescent tablets
stirling anglian pharmaceuticals ltd - acetylcysteine - effervescent tablet - 600 milligram(s) - mucolytics; acetylcysteine
acetylcysteine stirling anglian 600 mg effervescent tablets
stirling anglian pharmaceuticals ireland limited - acetylcysteine - effervescent tablet - 600 milligram(s) - mucolytics; acetylcysteine
acetylcysteine solution
sandoz canada incorporated - acetylcysteine - solution - 200mg - acetylcysteine 200mg - antidotes
acetylcysteine solution usp
hikma canada limited - acetylcysteine - solution - 200mg - acetylcysteine 200mg - antidotes
acetylcysteine 600mg tablets
special order - acetylcysteine - oral tablet - 600mg